Indian-American doctor indicted for sexually assaulting patients
Darpan News Desk IANS, 08 May, 2023 12:50 PM
New York, May 8 (IANS) An Indian-origin primary care physician in US' Georgia has been accused of sexually assaulting four of his female patients during routine check-ups over a 12-month period.
Rajesh Motibhai Patel, 68, was indicted last week on multiple counts of violating his patients' constitutional right to bodily integrity while acting under colour of law and for engaging in unwanted sexual contact, a Department of Justice release said.
According to information presented in court, between 2019 and 2020, Patel, a physician at the Veterans Affairs Medical Center in Decatur, allegedly assaulted four of his female patients by touching them improperly during routine exams. Investigators believe that Patel may have victimised additional patients.
"Patel allegedly sexually abused his female patients and violated his oath to do no harm to patients under his care," US Attorney Ryan K. Buchanan said.
"Veterans and their families expect and deserve the highest quality of healthcare delivered in a safe and accountable setting," Veteran Affairs Inspector General Michael J. Missal said.
He said that the department has been cooperating the law enforcement to ensure the safety of patients.
Many Indian Americans are wracked with guilt over emerging from more than a year of isolation as relatives overseas struggle to find vaccines, hospital beds and, fatefully, their breath.
Many of the 64 people affected either fainted or reported dizziness. Some got nauseous or vomited, and a few had racing hearts, chest pain or other symptoms.
In a statement Friday, the two pharmaceuticals said their submission to the European Medicines Agency is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective.
In the same breath, however, the speech marking Biden's first 100 days as commander-in-chief offered a measure of comfort by suggesting Buy American would not offend the terms of trade deals like the U.S.-Mexico-Canada Agreement.
So far, Pfizer's ongoing trial indicates the company's two-dose vaccine remains highly effective for at least six months, and likely longer. People who got Moderna’s vaccine also still had notable levels of virus-fighting antibodies six months after the second required shot.
